NCT00223665View on ClinicalTrials.gov

Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

January 8, 1997

Primary Completion Date

September 6, 2012

Study Completion Date

September 6, 2012

Conditions
Prostate Cancer
Interventions
DRUG

Flutamide

Flutamide dosed at 250mg orally three times a day for 14 days prior to the initiation of Leuprolide Acetate.

DRUG

Leuprolide Acetate

Leuprolide Acetate dosed at 7.5mg intramuscular (IM) injections once per month for a total of 9 months.

Trial Locations (1)

98109

Seattle Cancer Care Alliance, Seattle

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

University of Washington

OTHER